Clinical Trial Update: Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating neoadjuvant therapy with ifosfamide, doxorubicin, and hypofractionated radiotherapy for soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: AC Camargo Cancer Center | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: UNKNOWN